tiprankstipranks
Medicus Pharma Launches Convertible Note Offering
Company Announcements

Medicus Pharma Launches Convertible Note Offering

Medicus Pharma Ltd (TSE:MDCX) has released an update.

Don't Miss Our Christmas Offers:

Medicus Pharma Ltd. is initiating a private placement of convertible notes, aiming to raise up to $10 million with an initial closing of approximately $5.17 million. The notes, bearing 10% interest per annum, are set to mature at the end of 2025 and offer various conversion options to common shares, including automatic conversion under certain conditions before 2025 and optional conversion thereafter. This strategic financial move is geared towards bolstering the company’s capital structure with the assistance of EF Hutton LLC.

For further insights into TSE:MDCX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyMedicus Pharma initiated with a Buy at Maxim
TipRanks Canadian Auto-Generated NewsdeskMedicus Pharma Eyes Veterinary Market with FDA Designation
TheFlyMedicus Pharma announcs its INAD received MUMS from U.S. FDA
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App